Mineralys Therapeutics, Inc. (MLYS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Jon Congleton
|
President, CEO & Director | 1.11M | -- | 1963 |
|
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D.
|
Founder & Executive Director | -- | -- | 1977 |
|
Mr. Adam Scott Levy
|
CFO & Secretary | 880.19k | -- | 1978 |
|
Mr. Jeffrey A. Munsie J.D.
|
Chief Legal Officer | -- | -- | 1977 |
|
Dr. Robert McKean Ph.D.
|
Senior Vice President of CMC | -- | -- | -- |
|
Ms. Danielle Mahoney
|
Senior Vice President of Quality Assurance | -- | -- | -- |
|
Ms. Jessica Ibbitson
|
Executive Vice President of Operations | -- | -- | -- |
|
Mr. Eric J. Warren R.Ph.
|
Chief Commercial Officer | -- | -- | 1972 |
|
Mr. Michael Tortorici Ph.D., Pharm.D.
|
Senior Vice President of Translational Medicine | -- | -- | -- |
|
Dr. James J. Ferguson III, FACC, M.D.
|
Chief Medical Officer | -- | -- | 1954 |
Mineralys Therapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 76
Description
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Corporate Governance
Upcoming Events
November 4, 2026 at 8:00 PM UTC
Mineralys Therapeutics, Inc. Earnings Date
